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Abstract
 
We have studied the regulation of anti–DNA B cells in transgenic mice with a heavy chain
transgene (3H9H/56R). This transgene codes for a heavy chain that forms anti–double-
stranded DNA (dsDNA) antibody when paired with most members of the endogenous V
 
 
 
repertoire, but certain L chains, referred to as V
 
 
 
 editors, do not sustain dsDNA binding in
combination with 3H9H/56R. In the nonautoimmune 3H9H/56R BALB/c, most B cells
generated do not bind DNA because the transgene itself is edited or is associated with a V
 
 
 
 ed-
itor. A minor population of B cells (30%) bind dsDNA and express the 
 
 
 
1 light chain (known
to sustain 3H9H/56R DNA binding). These 3H9/56R/
 
 
 
1 B cells coexpress a 
 
 
 
 editor, and
we propose that the down-regulation of the anti-DNA BCR caused by the dual L chain ex-
pression may prevent activation of this 
 
 
 
/
 
 
 
 population. These 
 
 
 
/
 
 
 
 B cells are sequestered in
the marginal zone. Here, we studied the influence of autoimmunity on expression and regula-
tion of 3H9H/56R. In 3H9H/56R MRL/lpr mice, the expression of anti-dsDNA is vastly
accelerated. Anti–dsDNA B cells use noneditor 
 
 
 
s but, in addition, most anti–dsDNA B cells
have edited the heavy chain transgene. 
 
 
 
1 B cells (without the coexpression of a 
 
 
 
 editor) are
found and the 
 
 
 
/
 
 
 
1 MZ population is absent. Our results suggest that improper editing and
failure to sequester autoreactive B cells may contribute to the breakdown of tolerance in
MRL/lpr mice.
Key words: lupus • autoimmunity • isotype switch • tolerance • marginal zone
 
Introduction
 
Why tolerance fails is poorly understood, but transgenic
models have narrowed the range of possibilities. Central
tolerance to the facultative self-antigens, MHC in MRL-
lpr/lpr mouse
 
 (
 
MRL/lpr;
 
*
 
 reference 1) and HEL in lpr/lpr
mice (2), remains intact. Thus tolerance is broken at a later
stage of development in the lpr model of autoimmunity.
This leaves many possibilities because autoreactive B cells
are regulated in various ways in healthy mice, for example,
by inactivation or sequestration (3–5).
Anti-DNA is a good model for studying the sites at
which tolerance is broken. Regulation of anti-DNAs in
healthy mice takes place at several levels: anti–double-
stranded DNA (dsDNA) is regulated in the same manner as
anti-MHC, by receptor editing or deletion (6–8); anti–sin-
gle-stranded DNA is regulated by inactivation similar to
soluble hen egg lysozyme (4, 9). In addition, low affinity
anti-DNAs are found at high frequencies in B1 cells (10) or
the marginal zone (MZ; reference 11) and may escape self-
antigen activation in these sites. The 3H9H/V
 
 
 
8 trans-
genes code for an anti–single-stranded DNA, and the B
cells of this transgenic mouse are normally regulated by in-
activation (12). On the MRL/lpr background, 3H9H/V
 
 
 
8
B cells undergo clonal expansion and mutation, indicating
that tolerance by inactivation is broken in this model of au-
toimmunity (13).
The 3H9H/56R anti-DNA transgenic expresses several
types of anti-DNAs and is a convenient model for studying
the breakdown of self-tolerance in an autoimmune mouse
(14). Hybridoma panels derived from LPS-activated splenic
B cells of healthy mice show that the majority of B cells do
not express anti-DNA because the 3H9H/56R is edited or
paired with one of the few L chains that veto binding. A
minor fraction of B cells express anti-DNA, but these ex-
press more than one antibody. A prominent example of
such an “allelically included” B cell expresses a DNA-bind-
ing antibody made up of the 3H9H/56R and an L chain
that sustains binding such as 
 
 
 
1 and a non–DNA-binding
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antibody made up of the combination of 3H9H/56R and
an L chain editor. These 
 
 
 
/
 
 
 
 B cells are found in the MZ B
cell population (11). Thus, regulation of 3H9H56R B cells
takes place by receptor editing and by an unknown mecha-
nism that prevents these B cells from entering a secondary
immune response. Consequently, these mice do not de-
velop autoimmune disease although they do express IgM
anti-DNA antibody.
The 3H9H/56R MRL/lpr mouse provides the oppor-
tunity to study whether receptor editing and the arrest of
the 
 
 
 
/
 
 
 
 population are intact. Anti-DNA expression in the
transgenic MRL/lpr mouse is clearly influenced by the
3H9H/56R. The transgene vastly accelerates the rate at
which IgG anti-DNAs appear. In this paper, we have ana-
lyzed the B cells and a hybridoma panel from an 8-wk-old
3H9H/56R MRL/lpr mouse that expresses high titers of
IgM and IgG anti-DNA to determine the source of these
autoantibodies.
 
Materials and Methods
 
Mice.
 
Generation of site-directed heavy chain transgenic
3H9H/56R BALB/c mice is described in Li et al. (14). The line
was backcrossed for 
 
 
 
10 generations to MRL/lpr mice pur-
chased from The Jackson Laboratory.
 
Flow Cytometry.
 
Mice used in FACS
 
®
 
 analysis were between
6 and 8 wk old. Single cell suspensions were prepared from spleen
and stained with the following antibodies: PE-conjugated anti-
 
 
 
(187.1) (Southern Biotechnology Associates, Inc.); FITC-conju-
gated anti-CD19 (1D3); biotin-conjugated anti-
 
 
 
 (R26–46);
FITC-conjugated anti-CD21/CD35 (7G6); and PE-conjugated
anti-CD23 (B3B4) (BD Biosciences). Biotin-conjugated anti-idi-
otype antibody 1.209 has been described previously (6). Biotin-
conjugated antibodies were revealed by APC-conjugated strepta-
vidin (PharMingen). Dead cells were excluded by propidium
iodide staining. Stained cells were analyzed using a FACSort™
flow cytometer (Becton Dickinson) and CellQuest (Becton
Dickinson) software.
 
B Cell Hybridoma Generation.
 
Spleen cells from a 12-wk-old
3H9H/56R BALB/c mouse were stimulated in vitro for 3 d with
20 
 
 
 
g/ml LPS (Sigma-Aldrich), and unmanipulated spleen cells
from an 8-wk-old 3H9H/56R MRL/lpr mouse were fused in
separate experiments with SP2/0 myeloma cells. Hybridomas
were plated at limiting dilution in 96-well plates, and single colo-
nies were expanded for analysis. Genomic DNA was prepared as
described previously (15).
 
ELISA.
 
Antibodies secreted by hybridomas were analyzed by
solid-phase ELISA as described previously (15). Plates were
coated with anti-Ig and developed with alkaline phosphatase–
labeled anti–mouse H and L chains (to determine Ig secretors),
anti-IgM, anti-IgG, anti-
 
 
 
, or anti-
 
 
 
 (Southern Biotechnology
Associates, Inc.). The enzyme activities were revealed by the sub-
strate 
 
p
 
-nitrophenyl phosphate (Sigma-Aldrich) and optical densi-
ties were read at 405 nm. DNA binding assays were performed as
described previously (7).
 
PCR.
 
PCR for detection of the 3H9H/56R transgene has
been described in Li et al. (14). PCR testing for homozygosity of
the lpr gene is described in Chan and Shlomchik (16). Light chain
rearrangement at the 
 
 
 
 locus was analyzed using two types of
PCR. Vs PCR was performed as described in Brard et al. (13).
The Vs primer amplifies 80–90% of all mouse V
 
 
 
 genes (17), and
 
was used together with a J2 reverse primer (to detect V
 
 
 
/J1 rear-
rangement) or with a J5 reverse primer (to detect V
 
 
 
/J4 and V
 
 
 
/
J5 rearrangement; reference 18). The V
 
 
 
/J2 rearrangement can-
not be determined by the Vs PCR because the fusion partner
SP2/0 is positive in this reaction. To compensate for that, an-
other type of PCR was performed using L5 primer that detects
50–60% of V
 
 
 
 genes (19) together with the J2 reverse primer. C
 
 
 
deletion was detected using Vs as a forward primer and RS-101
as a reverse primer (20). PCR that detects 
 
 
 
 rearrangement was
performed as described previously (15).
 
Heavy Chain Sequencing.
 
To identify point mutations or VH
replacements in the heavy chain, we first sequenced the PCR
products of LD/CDR3 that detects the 3H9/56R heavy chain
transgene (14) from hybridomas that were transgene-positive.
Those hybrids that were transgene-negative can be explained by
point mutations in the CDR3 of the transgene or by VH replace-
ments. They were analyzed by an LD/JHCH PCR that uses a re-
verse primer downstream of CDR3 (13), and the PCR products
were sequenced to compare with the transgene. For those clones
that are negative for both the LD/CDR3 and LD/JHCH PCR,
the PCR using VH5.3 as forward primer and JHCH primer as
reverse primer was performed to reveal the VH replacement or
rearrangement of the endogenous allele. The VH5.3 is a degener-
ate primer that can amplify 
 
 
 
65% of VH genes (8). The se-
quences and positions of all these primers have been shown in
Brard et al. (13). The PCR products were gel-purified by
QIAquick Gel Extraction Kit (QIAGEN), and the sequence was
generated at the core facility of the Department of Molecular Bi-
ology (Princeton University).
 
 
 
 Light Chain Sequencing.
 
Total RNA was prepared from hy-
bridomas by TRIzol (GIBCO BRL). Reverse transcription was
done using the First-Strand cDNA Synthesis Kit (Amersham Bio-
sciences). The expressed 
 
 
 
 light chain was amplified by a forward
degenerate V
 
 
 
 primer (5
 
 
 
-GCCATGGAPRTQLWLMTSAC-
CCAGTCTCCA-3
 
 
 
; reference 21) and a reverse C
 
 
 
 primer (5
 
 
 
-
TGGATGGTGGGAAGATG-3
 
 
 
; reference 22). The PCR
products were sequenced using the C
 
 
 
 primer. For those clones
that express the 
 
 
 
 light chain, the out-of-frame rearranged 
 
 
 
 se-
quence was obtained by doing a Vs/J5 PCR on genomic DNA
from the hybridoma.
 
Results
 
Anti-DNA Antibodies in 3H9H/56R Mice.
 
Anti–DNA
B cells are differentially regulated in healthy mice. In the
conventional anti-DNA transgenics on a BALB/c genetic
background, no anti-DNA is expressed (4). Significant lev-
els of IgM anti-DNA are seen in the site-directed transgene
(sd-tg) 3H9H/56R BALB/c at the age of 6–8 wk (Fig. 1).
There seems to be a gradual loss of anti-DNA IgM, al-
though some mice tested at 12 wk still have significant ti-
ter. We do not understand this difference. However, no
IgG anti-DNA is expressed. Thus, the IgG anti-dsDNA
characteristic of Lupus is tightly regulated in BALB/c mice.
The presence of 3H9H/56R also affects anti-DNA ex-
pression in the MRL/lpr mouse. IgM anti-DNA titers are
higher in the sd-tg than the non-tg MRL/lpr. The unique
and Lupus-associated features of the MRL/lpr emerge in
our analysis of IgG anti-DNA. The 3H9H/56R signifi-
cantly accelerates the expression of IgG anti-DNA. We see
significant levels as early as 6 wk and titers peak by 8 wk, 
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whereas our MRL/lpr express IgG anti-dsDNA by 
 
 
 
10–
12 wk of age, and our BALB/c mice never express such
autoantibodies (Fig. 1). Thus, the sd-tg influences the rate
of IgG anti-DNA production in the MRL/lpr.
The 10–12-wk lag in autoantibody production in au-
toimmune mice has generally been interpreted to mean
that tolerance deteriorates with age. Our accelerated ap-
pearance of anti-DNA in the 3H9H/56R MRL/lpr argues
for a different interpretation, namely that the appearance of
autoreactive B cells determines the rate at which IgG anti-
DNA are expressed. Ordinarily, the probability that anti-
DNAs arise and escape central tolerance is low, but this
probability is vastly increased in the transgenic mouse be-
cause almost every B cell is anti-DNA from the beginning.
A similar argument has been advanced to explain the rela-
tively low frequency of expression of certain autoantibodies
such as Sm in aged MRL/lpr mice (23) and might also ap-
ply to differences in the time at which different autoanti-
bodies appear, for example, antichromatin before anti-
DNA in MRL/lpr mice (24). The sd-tg might accelerate
the onset of anti-DNA production by direct production of
anti-DNA, but alternatives such as increasing self-antigen
presentation must be considered. We have examined these
alternatives by analysis of the genes coding for the anti-
DNAs expressed by hybridomas from the 3H9H/56R
MRL/lpr.
 
Genetic Control of Anti-DNA from a 3H9H/56R MRL/lpr
Mouse: Hybridomas.
 
We assumed that the early expression
of anti-DNA would be directly due to the anti–DNA H
chain and that the anti-DNAs would be encoded by the
3H9H/56R. This prediction was tested by sequencing
anti-DNAs expressed by hybridomas derived from an
8-wk-old sd-tg. There is considerable evidence that such
panels are representative of the B cells that account for the
antibody profile of a mouse: among the evidence is similar-
ity of isotype and specificities. Another argument comes
from the observation that unmanipulated MRL/lpr B cells
yield hybridomas indicating the presence of activated B
cells (fusion efficiencies with unmanipulated B cells from
healthy mice are low). Presumably these B cells are respon-
sible for the serum antibody.
Fusions using spleen cells from unmanipulated spleen B
cells from 3H9H/56R MRL/lpr mice also yielded high
frequencies of hybridomas (Table I). A peculiarity of this
and other MRL/lpr hybridoma panels is the low percent-
age of secreting lines: only 32 (42%) secrete immunoglobu-
lin. A similar percentage was found in a second fusion of
this transgenic and other anti-DNA transgenics on the
MRL/lpr background (unpublished data). This percentage
is much lower than in 3H9H/56R BALB/c transgenics us-
ing either in vitro LPS-activated B cells (14) or KLH-
immunized B cells (8) for the fusions. Some of these hybrid-
omas have deleted the sd-tg and a fraction of these have 
 
 
 
rearrangements as well, suggesting that they are B cell-
derived. Others have no 
 
 
 
 rearrangement and their cellular
origin is in doubt. In this work, we have concentrated on
the bona fide B cell hybridomas.
The properties of the mAb panel parallel the serum anti-
body pattern of 8-wk-old tg MRL/lpr mice (Fig. 1 and
Figure 1. Anti-dsDNA in the sera of BALB/c and
MRL/lpr. 3H9H/56R BALB/c, 3H9H/56R MRL/lpr,
and their nontransgenic littermates were bled at 6, 8, and
12 wk. (Numbers of animals tested: BALB/c 6w, n   5;
3H9H/56R BALB/c 6w, n   4; MRL/lpr 6w, n   4;
3H9H/56R MRL/lpr 6w, n   8; BALB/c 8w, n   5;
3H9H/56R BALB/c 8w, n   4; MRL/lpr 8w, n   3;
3H9H/56R MRL/lpr 8w, n   9; BALB/c 12w, n   7;
3H9H/56R BALB/c 12w, n   7; MRL/lpr 12w, n   4;
3H9H/56R MRL/lpr 12w, n   5.) Serum samples were
tested for anti-dsDNA IgM and IgG by ELISA at 1:100
dilution.
 
Table I.
 
Comparison of the Hybridomas from 3H9H/56R 
BALB/c and 3H9H/56R MRL/lpr
 
3H9H/56R BALB/c
 
a
 
3H9H/56R MRL/lpr
 
b
 
Isotypes 81 IgM; 2 IgG 7 IgM; 25 IgG
dsDNA binder 10 out of 83 (12%) 11 out of 32 (34%)
3H9H56R Tg–positive
clones 69 (83%) 8 (25%)
C
 
 
 
 deletion 9 (11%) 6 (19%)
Results are from a single mouse of each background that expresses the sd-tg 
in a heterozygous state.
 
a
 
LPS-stimulated fusion.
 
b
 
Spontaneous fusion. 
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Table I). About 30% secrete anti-dsDNA. Of these, 9/11
are IgG and 2/11 are IgM. The rest of the mAbs do not
bind DNA even though the majority are IgGs. A similar
distribution of DNA-binding mAbs was seen in a system-
atic study of non-tg MRL/lpr mAbs. In this case, the non–
anti-DNA mAbs had other Lupus specificities such as anti-
IgG, anti-Sm, and antihistone as well as a population that
was not reactive to a panel of Lupus autoantigens (25). We
presumed acquisition of specificities other than anti-DNA
in the sd-tg MRL/lpr would be accompanied by transgene
modification such as VH replacement (8) and/or L chain
editing (6).
 
Heavy and Light Chain Usage in Anti–DNA B Cells.
 
We studied the heavy and light chain rearrangement in the
hybridomas of transgenic mice using VH and VL region
PCRs (Table II). Only 8/32 (25%) Ab secretors from
3H9H/56R MRL/lpr have an intact 3H9H/56R sd-tg.
Loss of the sd-tg was due to VH and DH replacement
(clones 25, 26, 46, and 75). Why the sd-tg is lost in the rest
of the secretors is not understood. In the 3H9H, the sd-tg
 
Table II.
 
Characteristics of Hybridomas from 3H9H/56R MRL/lpr
 
Clone Isotype
dsDNA
binding H chain tg L chain usage
C
 
  
 
deletion
28 IgM
 
     
 
v
 
 
 
21-10/J2 –
54 IgM
 
     
 
v
 
 
 
19-15/J5 –
5 IgG
 
    
 
v
 
 
 
ba9/J5 –
48 IgG
 
     
 
 with mutation v
 
 
 
23-45/J2
 
 
 
57 IgG
 
     
 
 with mutation
 
 
 
x–
31 IgM –
 
 
 
v
 
 
 
21-D/J1 –
44 IgM –
 
  
 
x
 
 
69 IgG –   with mutation v 21-1/J5 –
15 IgG   endogenous allele expression v cr1/J1 –
26 IgG   V-replacement v cb9/J4 –
35 IgG   –N D  
39 IgG    –v  bd2/J5(OF);  1  
46 IgG    V-replacement v 19-23/J4 –
75 IgG     V-replacement v hg24/J4(OF);  1  
17 IgM – – J2 –
30 IgM – – J1 –
4 IgG – – J1 –
18 IgG – – J2 and J4 –
21 IgG – – ND –
21 IgG – – ND –
22 IgG – – J2 –
23 IgG – – J2 and J5 –
25 IgG – V-replacement J1 –
29 IgG – – J1 and J5 –
33 IgG – – J1 –
34 IgG – – J1 and J5 –
47 IgG – – ND –
50 IgG – – ND –
60 IgG – – ND –
70 IgG – –  1–
72 IgG – – J1 and J4 –
73 IgG – – J5  
76 IgG – – J2 and J5 –
All 32 hybridomas that secrete immunoglobulin are listed. Their isotypes (IgM or IgG) and dsDNA binding capacities are shown. The heavy chain
transgene status in each hybridoma is shown as positive or negative according to the PCR described in Materials and Methods. Point mutations, VH
replacements, and endogenous allele expression are also indicated. The light chain rearrangement and expression are shown according to both PCR
and sequencing results. The expression of   is confirmed by ELISA. OF, out-of-frame rearrangement on the   allele. ND, light chain rearrangements
not determined. Those clones that were positive in the PCR detecting C  deletion are also indicated.1547 Li et al.
was truncated by DH rearrangement to the internal hep-
tamer (8). These clones now express H chains coded for by
the untargeted allele.
The 3H9H/56R MRL/lpr model provides an opportu-
nity to ask whether L chain editing occurs in this model of
autoimmunity. In healthy mice, all sd-tg antibodies are al-
ways associated with   or   editors with the exception of
double expressers such as the 3H9H/56R  /  population
(11). Anti-DNA mAbs from autoimmune mice are associ-
ated with many   chains and  1 but not the set of   chains
and  x known to edit anti-DNAs. These antibodies in-
clude H chains coded for by the 3H9H/56R gene or other
closely related members of the J558 family (26). However,
edited mAbs are found among the 3H9H/56R MRL/lpr
hybridomas. Clones 31 and 44 each expresses an editor
(V 21-D and  x, respectively), and neither of them binds
DNA (Table II). Thus central tolerance is at least partially
intact in the MRL/lpr as described previously (1). In addi-
tion, we find 3H9H/56R anti-DNAs with noneditor  s or
 1 (Tables II and III). These may have arisen because cen-
tral tolerance is incomplete in MRL/lpr mice or because of
ongoing rearrangement that replaces   editors with L
chains that sustain DNA binding.
A property of Lupus-associated autoantibodies is somatic
mutation. The pattern of mutations shows evidence for anti-
gen selection and mutations in anti-DNAs have been shown
to create and modify DNA binding (27). Given that these
MRL/lpr mice inherit a relatively high affinity anti-DNA,
whether they undergo mutation and whether anti-DNA ac-
tivity is modified is relevant. We could address this question
because certain 3H9H/56R antibodies are not edited. The
IgM anti-DNAs have no mutations (This applies just to VH;
we are not sure about the germline sequences of the L chains
expressed in this strain). The IgG anti-DNAs have multiple
mutations and the mutation pattern shows evidence for se-
lection. 10/14 replacements occur in CDRs or other sites
that contribute to DNA binding, and 5/10 mutants are to
arginines or asparagines, which are residues that favor DNA
binding (Fig. 2). Clone 69 does not bind DNA even though
it is associated with a   chain that should sustain DNA bind-
ing (22). Lack of DNA binding might result from arginine
97 to serine mutation or the potentially negative effect of the
mutation of the highly conserved tyrosine 93 to cysteine.
In the anti-dsDNA IgG clones with VH replacements
(clones 46, 26, and 75), mutations are also found (Fig. 3). It
Table III. Comparison of Anti–DNA B Cells from 3H9H/56R 
BALB/c and 3H9H/56R MRL/lpr
3H9H/56R BALB/c 3H9H/56R MRL/lpr
L chain usage L chain usage
H chain transgene   9 IgM:  1 and a   editor 2 IgM: V 21-10; V 19-15
0 IgG
3 IgG V ba9; V 23-45; 
1 unknown  
H chain transgene   1 IgM: unknown   0 IgM
0 IgG
6 IgG V cr1; V cb9; 
V 19-23;  1
The isotypes, heavy and light chain usage of anti–DNA B cells from 3H9H/
56R BALB/c and 3H9H/56R MRL/lpr are shown.
Figure 2. Heavy chain sequences of B cells that
retain the H chain transgene. The nucleotide and
deduced amino acid sequences of heavy chains
from hybridomas that are transgene-positive are
aligned with 3H9H/56R transgene sequence. Mu-
tations in the IgG-secreting clones (5, 48, 57, and
69) are indicated. A silent mutation in the FWR2
of clone 57 is shown in lowercase letter.1548 Anti-DNA B Cells in MRL/lpr Mice
is interesting to note that the arginine mutation in the FR2
of clone 75 is shared by clone 57 (and other anti-DNAs in
the literature; reference 26). This site is superficial and
could contribute to DNA binding. In these VH genes, argi-
nines are found in the newly formed D junctions due to ei-
ther N-addition or point mutation (Fig. 3 B). Another
source of an arginine codon is a VH replacement that cap-
tures a short sequence from the end of the recipient VH
gene (in this case the transgene). In the transgene as well as
most VH genes, this sequence includes an arginine codon
(Fig. 3 B, clones 46 and 75). These mechanisms by which
anti-DNAs are modified or created play a central role in
autoantibody formation in the non-tg MRL/lpr. It is sur-
prising that the sd-tg resorts to these mechanisms because
the inherited 3H9H/56R (along with most L chains) con-
tributes to high affinity DNA binding. Therefore, it appears
the emerging 3H9H/56R B cells must have undergone
prior modifications that necessitate de novo development of
anti-DNA. These could include VH replacement, somatic
mutation (in two instances critical Args in 3H9H/56R have
mutated to a neutral amino acid), and L chain editing.
3H9H/56R MRL/lpr Mice Have Fewer  /  Double-posi-
tive MZ B Cells than 3H9H/56R BALB/c Mice. Early
work (14) showed that the  1, in combination with 3H9H/
56R, binds dsDNA. Such autoreactive B cells are seen in
3H9H/56R BALB/c. However, they always coexpress a  
editor such as V 21-D or V 38C (14). Nonautoimmune
3H9H/56R tg mice also have a population of B cells that
coexpress  /  light chains (11). The frequency of this pop-
ulation increases with age and reaches a maximum of  30%
of the B220  B cells population (11). These mice do not
express these anti-DNAs, and we presume that they are
negatively regulated by inactivation or sequestration. Indeed
the majority of the  /  population is in the MZ.
In 3H9H/56R MRL/lpr hybridoma panel, we found
two clones that express  1 without the coexpression of a  
Figure 3. Heavy chain sequence of B cells that have ed-
ited the H chain transgene. (A) The nucleotide and de-
duced amino acid sequences of the V regions of heavy
chains from hybridomas that are transgene-negative (clones
15, 46, 26, and 75) are shown. VH gene usage and point
mutations compared with each of their germline sequences
from the NCBI database are indicated. (B) CDR3 regions
of the heavy chains of hybridomas (clones 46, 26, and 75)
that had VH replacement are shown. The N-additions at
the newly formed D-junctions, the remaining D and J4 re-
gion of the 3H9H/56R transgene and point mutations are
indicated. Another heavy chain from clone 15 is generated
by endogenous rearrangement on the untargeted allele, in-
dicated by the differences at the JH region (marked by as-
terisk) between the transgene (a-allotype) and endogenous
JH4 (j-allotype). The mutations compared with its germ-
line sequence are also shown.1549 Li et al.
editor (Table II, clones 39 and 75). Instead, both of them
have one   allele that has out-of-frame rearrangement and
C  deletion on the other allele. We wondered whether
they were derived from the  /  population, and whether
the kind of tolerance represented by this phenotype was
operating in the MRL/lpr.
The peak frequency of  /  double-positive B cells is
lower in 3H9H/56R MRL/lpr (7.6% of the CD19  spleen
B cell) than in 3H9H/56R BALB/c (19.4%; Fig. 4). The  / 
double-positive B cells of 3H9H/56R BALB/c are in the
marginal zone shown by markers such as CD21high and
CD1high. Most of the  /  double-positive B cells in 3H9H/
56R MRL/lpr are CD21low and CD1low, indicating that
they are not in the marginal zone (Fig. 5). As has been previ-
ously reported, there is a general decrease in CD21 and
CD23 level in MRL/lpr mice (28). However, there is no
generalized defect in MZ B cell development. As shown in
Fig. 6 A, non-tg MRL/lpr mice has a larger MZ B cell pop-
ulation (CD21high, CD23low; 10.8% of lymphoid gate) com-
pared with non-tg BALB/c (1.9%). The exaggerated MZ of
MRL/lpr mice has also been reported before (29). Most in-
terestingly, although the 3H9H/56R transgene causes a big
increase of the MZ B cells population in BALB/c, it dramat-
ically reduces that population in MRL/lpr (Fig. 6 A). Sev-
eral mouse strains with transgene have shown larger MZ
B cell compartment, which can accommodate self-reactive B
cells (for review see reference 30). The reduction of MZ B
cell population in3H9H/56R MRL/lpr shows some unique
feature of MRL/lpr not only different from BALB/c, but
also different from other autoimmune mice such as NZB/W,
as pronounced marginal zone compartment was observed
NZB/W mice with an anti-DNA  H transgene (31).
Expression of the heavy chain transgene was investigated
by using a mAb, 1.209, that recognizes the 3H9 heavy
chain. 3H9H/56R MRL/lpr mice have fewer 1.209 cells
in the spleen (2.9%) than 3H9H/56R BALB/c (10.3%),
suggesting that there is more heavy chain editing in MRL/
lpr mice. In addition, although the majority (67%) of the
Id  B cells of 3H9H/56R BABL/c are in the marginal
zone (shown by CD21high), most of the Id  B cells (76%) of
3H9H/56R MRL/lpr are CD21low (Fig. 6 B).
Discussion
Stochastic Processes Determine the Onset of Autoimmunity.
Stochastic processes can explain the variable spectrum of
autoantibodies in individuals with Lupus. Certain autoanti-
bodies are expressed in subsets of Lupus patients; for exam-
ple, the Lupus autoantibody Sm is observed in just 25% of
MRL/lpr mice. Exhaustive searches for an epigenetic basis
for the variability were unsuccessful, leaving the alternative
that acquisition of an Sm receptor occurs with a probability
that guarantees expression in  25% of the population. The
frequency of anti-DNA is higher than Sm (32) which, ac-
cording to the stochastic model, means that the probability
of acquiring an anti-DNA receptor is higher than that for
Sm. That acquisition of anti-DNA receptors is highly likely
is supported by studies on the genetic basis of this specific-
ity. DNA binding is strongly correlated with arginine resi-
dues in the CDR3 of VH and arginine codons often
formed during V(D)J rearrangement (33).
Another variable feature of autoimmunity is the timing
of autoantibody expression. Although most MRL/lpr mice
express anti-DNA by 10 to 12 wk of age, the onset of anti-
DNA expression is variable from mouse to mouse. Even
Figure 4.   and   expression in spleen B
cells. Spleen cells from 3H9H/56R BALB/c,
3H9H/56R MRL/lpr, and their nontrans-
genic littermates were stained with anti-
CD19,  , and  . Percentages of   ,   , and
 /   cells in a CD19  gate are indicated.
Representative of experiments using three
different mice of each kind.
Figure 5. CD21 and CD1 expression levels of  /  double-positive
cells are different between 3H9H/56R BALB/c and 3H9H/56R MRL/
lpr. Spleen cells from 3H9H/56R BALB/c and 3H9H/56R MRL/lpr
were stained with anti-CD21, CD1,  , and  . Histograms of CD21 and
CD1 expression are shown for the  /  double-positive (filled area) and  
single-positive (thin line) populations.1550 Anti-DNA B Cells in MRL/lpr Mice
though the normal process of V(D)J often yields anti-DNA
receptor genes, the frequency may not be high enough to
prevent a lag in anti-DNA expression in Lupus mice. (It
should be pointed out that influence of the anti-DNA
sd-tg on the frequency and rate of anti-DNA expression de-
scribed here is in the context of the autoimmune MRL/lpr
mouse.) If during V(D)J rearrangement, acquisition of an
anti-DNA receptor is likely but not a certainty, then the
variability of expression is expected. In turn it would be
expected that the sd-tg would influence the appearance of
anti-DNA expression in MRL/lpr mice. This is the case
and anti-DNA expression is accelerated by several weeks in
sd-tg MRL/lpr mice (Fig. 1). This result suggests that the
acquisition of an anti-DNA receptor may be a rate-limiting
step in Lupus and inheritance of a preformed anti-DNA
receptor (as in the case of 3H9H/56R mice) overcomes
this step.
An obvious prediction of this model is that the sd-tg H
chain will dominate the anti-DNA response. Based on our
sequence analysis of mAbs derived from the MRL/lpr sd-tg
this is not the case, only half of the anti-DNA mAbs H
chains recovered from a fusion using unmanipulated spleen
B cells are encoded by the sd-tg (Table III). Thus, the ef-
fect of the sd-tg on anti-DNA expression is, in part, indi-
rect. B cells with the sd-tg–encoded receptor may be sub-
jected to extended periods of rearrangement leading to
reediting. The clones that secrete anti-DNA antibodies and
retain the sd-tg use noneditors, i.e., the light chains that
sustain DNA-binding such as V 21–10, V 23–45, V 19–
15, V ba9, and  1 (Tables II and III), and they may have
arisen after editing as a result of ongoing rearrangement and
reediting to recover the initial (anti-DNA) specificity.
Anti-DNAs encoded by endogenous VH genes have
CDR3 regions characteristic of Lupus anti-DNAs. Such
CDR3 sequences are thought to arise by extended periods
of rearrangement that creates these sequences and leads to
their utilization by inactivation of the original V(D)J allele
(in this case, the sd-tg–encoded allele; reference 34). We
cannot rule out that these anti-DNAs arose because of a
failure to edit as in the case of the sd-tg–encoded anti-
DNAs or because of failure of the sd-tg to efficiently ex-
clude rearrangement, as in the case of the anti-DNAs en-
coded by the untargeted allele. However, the frequency of
rearrangement events found in the MRL/lpr hybridomas is
high. The frequency of VH replacement and inactivation is
much higher than that in LPS-activated tg-B cell hybrid-
omas (14) or B cells from KLH-immunized transgenics (8).
Even the 11 hybridomas that secrete anti-DNAs have low
frequencies of sd-tg retention: five clones, two IgM (clones
28 and 54) and three IgG (clones 26, 46, and 75), retain the
transgene. The other six clones, all IgG, have replaced or
inactivated the sd-tg. Along with the extensive loss of the
sd-tg, we also find a high frequency of C  deletion in these
hybridomas, hence we favor the reediting hypothesis as an
explanation for the origin of anti-DNAs in the Lupus mice.
Nonspecific and Specific Activation in MRL/lpr. The ori-
gin of anti-DNA in Lupus is complex and expression has
been linked to different sets of B cells. Autoantibodies are
expressed by the hyperactive B cells of the MRL/lpr.
These antibodies have the range of self-specificities ex-
pressed by mitogen-activated B cells. Typically they are
IgM and in LPS panels such “natural” or “germline au-
toantibodies” are not mutated (35). mAbs with these prop-
erties are found in this panel. The anti–DNA H chain is
coded for by the sd-tg and is associated with L chains that
sustain DNA binding. Here, the tg VH is unmutated (Fig.
2, clones 28 and 54). The anti-dsDNAs characteristic of
Lupus are IgG, oligoclonal, and mutated. This type of anti-
DNA is also found among the sd-tg MRL/lpr.
We wish to know if there is a connection between these
populations. One possibility is that they are of independent
origin. The sd-tg may not completely exclude VH rear-
rangement (9), and a population of B cells with VH re-
placements or endogenous V(D)J genes may arise early in
development and contribute to the adult autoantibody rep-
ertoire. This pathway would not explain the accelerated
Figure 6. Marginal zone B cells and Id  B cells in
3H9H/56R BALB/c and 3H9H/56R MRL/lpr.
Spleen cells from 3H9H/56R BALB/c, 3H9H/56R
MRL/lpr, and their nontransgenic littermates were
stained with anti-CD21, CD23, and anti–Id 1.209.
Percentages of MZB cells (CD21highCD23low),
Id CD21high, Id CD21low, and Id CD21high cells from
a lymphocyte gate are indicated.1551 Li et al.
onset of anti-DNA in the sd-tg, if anything, one might ex-
pect delayed expression of autoantibodies by this model.
Alternatively, the IgM or hyperactive population may be
the precursor of the IgG-secreting B cells. Regulation of
this population may be lost or the population—by virtue of
its anti-DNA receptor—may gain the potential for entering
the memory B cell population. The first case might lead to
the shift to tg-encoded IgG anti-DNA as in the case of
clone 48 and 57. The second case could yield the diverse
repertoire of anti-DNAs as in clones 26, 46, and 75. Here,
the tg might contribute to the frequency of B cells that can
present antigen to autoreactive T cells. The fate of these B
cells is uncertain, they are likely to undergo isotype switch
and mutation. In addition, V gene rearrangement might be
stimulated leading to the novel V gene repertoires found
among these IgG anti-DNAs.
Failure to Sequester Self-reactive B Cells May Lead to Au-
toimmunity. The 3H9H/56R BALB/c expresses high fre-
quencies of tolerant B cells that arise by “phenotypic edit-
ing.” This form of editing occurs when secondary (editing)
rearrangements do not delete the autoreactive V gene, but
take place on its allele or at other L chain isotypes ( 1,   2,
etc.). These B cells express two L chains, for example, two
  chains (6), one of which is an editor, or as is frequently
the case in 3H9H/56R,  1 and a   editor (14). We pro-
pose that dual expression dilutes the anti-DNA receptor
and renders the cell inactive. The  /  B cells are concen-
trated in the MZ, and sequestration to this site may prevent
autoreactive B cells from entering germinal centers and de-
veloping the properties of pathogenic B cells. We exam-
ined these  /  B cells in MRL/lpr and found that the se-
questration is defective. Failure to sequester self-reactive B
cells also has been observed in B1 cells. Anti–erythrocyte
B1 cells become activated and differentiated in antibody-
producing cells in mesenteric lymph nodes and lamina pro-
pria of intestine in Fas-deficient mice (36). Anti-Sm B1
cells in normal mice also fail to develop in MRL/lpr mice
(37). Together, failure to sequester self-reactive B cells in
regions such as the MZ or peritoneal cavity may contribute
to the loss of tolerance.
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